IASO BioTherapeutics (驯鹿医疗)

Nanjing, China

Drug Development Cancer Care Biotech Therapeutics

IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and autoimmune diseases. Leveraging its proprietary fully human antibody discovery platform (IMARS), high-throughput CAR-T drug priority platform, and proprietary manufacturing processes, IASO Bio is developing a rich clinical-stage pipeline of multiple autologous and allogeneic CAR-T and biologics product candidates.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out IASO BioTherapeutics (驯鹿医疗) on @MedStartr Today #CancerResearchAndTreatment #CancerOncology #DrugDevelopment #CancerCare #Biotech #Therapeutics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/X49rnZbGwa4

Get Involved in IASO BioTherapeutics (驯鹿医疗)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: www.iasobio.com/

Disease Areas

Cancer Research and Treatment Cancer & Oncology

Technologies

Drug DevelopmentBiotherapeuticsBiotechnologyTherapeutics

🌐Website

What do you think of IASO BioTherapeutics (驯鹿医疗)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.